Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder

Small-cell cancer of the urinary bladder is a rare but highly aggressive disease. It is currently unclear whether immune checkpoint therapies that have been approved for urothelial carcinomas will also be efficient in small-cell carcinomas. In this study, we analyzed potential predictors of response...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandelkow, Tim, Blessin, Niclas C., Lueerss, Eva, Pott, Laura, Simon, Ronald, Li, Wenchao, Wellge, Björn, Debatin, Nicolaus F., Höflmayer, Doris, Izbicki, Jakob R., Büscheck, Franziska, Luebke, Andreas M., Wittmer, Corinna, Jacobsen, Frank, Lutz, Florian, Burandt, Eike, Steurer, Stefan, Sauter, Guido, Tsourlakis, Maria Christina, Wilczak, Waldemar, Hinsch, Andrea, Minner, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525886/
https://www.ncbi.nlm.nih.gov/pubmed/31191745
http://dx.doi.org/10.1155/2019/2532518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525886/
https://www.ncbi.nlm.nih.gov/pubmed/31191745
http://dx.doi.org/10.1155/2019/2532518

Ejemplares similares